63
Growth Score
pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
494084
Vaneltix Pharma focuses on urology and women's health, offering Alenura™ for Interstitial Cystitis/Bladder Pain Syndrome.
C. Lowell Parsons: Chairman and Founder
About the Company
Vaneltix Pharma specializes in urology and women's health care, focusing on providing immediate relief for patients suffering from Interstitial Cystitis/Bladder Pain Syndrome. The company is involved in the development and commercialization of Alenura™, a combination product of glycosaminoglycan heparin and alkalinized lidocaine. Vaneltix
conducts clinical trials across the US and holds worldwide IP covering use, composition, and manufacturing. The company also utilizes a plasmid-based, muscle-specific GeneSwitch system for regulated gene expression in skeletal muscle.
